Ventricular Enlargement and its Clinical Correlates in the Imaging Cohort From the ADCS MCI Donepezil/Vitamin E Study-Reference-Cited by-同舟云学术

Ventricular Enlargement and its Clinical Correlates in the Imaging Cohort From the ADCS MCI Donepezil/Vitamin E Study

Published:2013-04 Issue:2 Volume:27 Page:174-181
ISSN:0893-0341
Container-title:Alzheimer Disease & Associated Disorders
language:en
Short-container-title:

Author:

Apostolova Liana G.,Babakchanian Sona,Hwang Kristy S.,Green Amity E.,Zlatev Dimitar,Chou Yi-Yu,DeCarli Charlie,Jack Clifford R.,Petersen Ronald C.,Aisen Paul S.,Cummings Jeffrey L.,Toga Arthur W.,Thompson Paul M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Gerontology,Clinical Psychology

Reference23 articles.

1. Ventricular volume and dementia progression in the Cardiovascular Health Study.;Carmichael;Neurobiol Aging,2007

2. Ventricular maps in 804 ADNI subjects: correlations with CSF biomarkers and clinical decline.;Chou;Neurobiol Aging,2010

3. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD.;Jack;Neurology,2004

4. Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimers disease, mild cognitive impairment and elderly controls.;Chou;Neuroimage,2009

5. Automated ventricular mapping with multi-atlas fluid image alignment reveals genetic effects in Alzheimers disease.;Chou;Neuroimage,2008

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Automatization and validation of the hippocampal-to-ventricle ratio in a clinical sample;2024-04-15

2. Prognostic enrichment for early-stage Huntington’s disease: An explainable machine learning approach for clinical trial;NeuroImage: Clinical;2024

3. Importance of Neuroimaging in Infants with Microcephaly;Newborn;2023-06-30

4. Challenges and opportunities of diagnostic markers of Alzheimer's disease based on structural magnetic resonance imaging;Brain and Behavior;2023-02-16

5. Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer’s disease;Brain Communications;2023